Skip to main content
SpringerLink
Log in

Sleep Disturbance in Tourette’s Disorder: Potential Underlying Mechanisms

  • SLEEP AND NEUROLOGICAL CONDITIONS (A AVIDAN, SECTION EDITOR)
  • Published:
Current Sleep Medicine Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

Sleep disturbance is common in TD. However, our understanding of the pathophysiological mechanisms involved is preliminary. This review summarizes findings from neuroimaging, genetic, and animal studies to elucidate potential underlying mechanisms of sleep disruption in TD.

Recent Findings

Preliminary neuroimaging research indicates increased activity in the premotor cortex, and decreased activity in the prefrontal cortex is associated with NREM sleep in TD. Striatal dopamine exhibits a circadian rhythm and is influenced by the suprachiasmatic nucleus via multiple molecular mechanisms. Conversely, dopamine receptors regulate circadian function and striatal expression of circadian genes. The association of TD with restless legs syndrome and periodic limb movements indicates shared pathophysiology, including iron deficiency, and variants in the BTDB9 gene. A mutation in the L-Histidine Decarboxylase gene in TD suggests the involvement of the histaminergic system, implicated in arousal, in TD.

Summary

These biological markers have implications for application of novel, targeted interventions, including noninvasive neuromodulation, iron supplementation, histamine receptor antagonists, and circadian-based therapies for tic symptoms and/or sleep and circadian rhythms in TD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. American Psychiatric Association. 5th ed. Diagnostic and statistical manual for mental disorders. Washington, DC: 2013.

  2. Tinker SC, Bitsko RH, Danielson ML, Newsome K, Kaminski JW. Estimating the number of people with Tourette syndrome and persistent tic disorder in the United States. Psychiatry Res. 2022;114684.

  3. Robertson MM, Eapen V, Singer HS, Martino D, Scharf JM, Paschou P, et al. Gilles de la Tourette syndrome. Nat Rev Dis Primers. 2017;3(1):1–20.

    Article  Google Scholar 

  4. Bloch MH, Leckman JF. Clinical course of Tourette syndrome. J Psychosom Res. 2009;67(6):497–501.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Evans J, Seri S, Cavanna AE. The effects of Gilles de la Tourette syndrome and other chronic tic disorders on quality of life across the lifespan: a systematic review. Eur Child Adolesc Psychiatry. 2016;25(9):939–48. https://doi.org/10.1007/s00787-016-0823-8.

    Article  PubMed  PubMed Central  Google Scholar 

  6. • Hirschtritt ME, Lee PC, Pauls DL, Dion Y, Grados MA, Illmann C, et al. Lifetime prevalence, age of risk, and genetic relationships of comorbid psychiatric disorders in Tourette syndrome. JAMA Psychiatry. 2015;72(4):325–33. This comprehensive study provides clinical and epidemiological data for Tourette’s disorder using a controlled design.

  7. Jiménez-Jiménez FJ, Alonso-Navarro H, Garcia-Martin E, Agundez JA. Sleep disorders in Tourette syndrome. Sleep Med Rev. 2020;53:101335.

    Article  PubMed  Google Scholar 

  8. Groth C, Debes NM, Rask CU, Lange T, Skov L. Course of Tourette syndrome and comorbidities in a large prospective clinical study. J Am Acad Child Adolesc Psychiatry. 2017;56(4):304–12.

    Article  PubMed  Google Scholar 

  9. Sambrani T, Jakubovski E, Müller-Vahl KR. New insights into clinical characteristics of Gilles de la Tourette syndrome: findings in 1032 patients from a single German center. Front Neurosci. 2016;10:415. https://doi.org/10.3389/fnins.2016.00415.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Ricketts EJ, Rozenman MR, Choy C, Goldberg HB, Kim JS, Colwell CS, et al. Sleep sufficiency in pediatric and adolescent Tourette’s disorder: national survey of children’s health. J Dev Behav Pediatr. 2018;39(1):72.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Isomura K, Sidorchuk A, Sevilla-Cermeño L, Åkerstedt T, Silverberg-Morse M, Larsson H, et al. Insomnia in Tourette syndrome and chronic tic disorder. Mov Disord. 2022;37(2):392–400.

    Article  CAS  PubMed  Google Scholar 

  12. Ghosh D, Rajan PV, Das D, Datta P, Rothner AD, Erenberg G. Sleep disorders in children with Tourette syndrome. Pediatr Neurol. 2014;51(1):31–5. https://doi.org/10.1016/j.pediatrneurol.2014.03.017.

    Article  PubMed  Google Scholar 

  13. Ricketts EJ, Montalbano GE, Burgess HJ, McMakin DL, Coles ME, Piacentini J, et al. Sleep and chronotype in adults with persistent tic disorders. J Clin Psychol. 2022;78(7):1516–39. https://doi.org/10.1002/jclp.23323.

    Article  PubMed  Google Scholar 

  14. Lesperance P, Djerroud N, Diaz Anzaldua A, Rouleau GA, Chouinard S, Richer F, et al. Restless legs in Tourette syndrome. Mov Disord. 2004;19(9):1084–7. https://doi.org/10.1002/mds.20100.

    Article  CAS  PubMed  Google Scholar 

  15. Modafferi S, Stornelli M, Chiarotti F, Cardona F, Bruni O. Sleep, anxiety and psychiatric symptoms in children with Tourette syndrome and tic disorders. Eur J Paediatr Neurol. 2016;20(5):696–703. https://doi.org/10.1016/j.ejpn.2016.05.003.

    Article  PubMed  Google Scholar 

  16. Voderholzer U, Muller N, Haag C, Riemann D, Straube A. Periodic limb movements during sleep are a frequent finding in patients with Gilles de la Tourette’s syndrome. J Neurol. 1997;244(8):521–6. https://doi.org/10.1007/s004150050136.

    Article  CAS  PubMed  Google Scholar 

  17. Mendelson WB, Caine ED, Goyer P, Ebert M, Gillin JC. Sleep in Gilles de la Tourette syndrome. Biol Psychiatry. 1980;15:339–43.

    CAS  PubMed  Google Scholar 

  18. Cohrs S, Rasch T, Altmeyer S, Kinkelbur J, Kostanecka T, Rothenberger A, et al. Decreased sleep quality and increased sleep related movements in patients with Tourette’s syndrome. J Neurol Neurosurg Psychiatry. 2001;70(2):192–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Glaze DG, Frost JD, Jankovic J. Sleep in Gilles de la Tourette’s syndrome: disorder of arousal. Neurology. 1983;33(5):586.

    Article  CAS  PubMed  Google Scholar 

  20. Silvestri R, Raffaele M, De Domenico P, Tisano A, Mento G, Casella C, Tripoli MC, Serra S, Di Perri R. Sleep features in Tourette’s syndrome, neurocanthocytosis and Huntington’s chorea. Neuropysiological Clinics. 1995;25:66–77.

    Article  CAS  Google Scholar 

  21. Drake ME Jr, Hietter SA, Bogner JE, Andrews JM. Cassette EEG sleep recordings in Gilles de la Tourette syndrome. Clin Electroencephalogr. 1992;23(3):142–6.

    Article  PubMed  Google Scholar 

  22. Kirov R, Brand S, Banaschewski T, Rothenberger A. Opposite impact of REM sleep on neurobehavioral functioning in children with common psychiatric disorders compared to typically developing children. Front Psychol. 2017;7:2059.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Kostanecka-Endress T, Banaschewski T, Kinkelbur J, Wüllner I, Lichtblau S, Cohrs S, et al. Disturbed sleep in children with Tourette syndrome: a polysomnographic study. J Psychosom Res. 2003;55(1):23–9.

    Article  PubMed  Google Scholar 

  24. Tulen JH, Niers T, Vegt R, Cath D, Hengeveld MW. Sleep quality and motor activity during sleep in adults with ADHD or Tourette’s disorder. Sleep-Wake Res Netherlands. 2007;18:119–22.

    Google Scholar 

  25. Pringsheim T, Nosratmirshekarlou E, Doja A, Martino D. Physical activity, sleep and neuropsychiatric symptom severity in children with Tourette syndrome. Eur Child Adolesc Psychiatry. 2021;30(5):711–9.

    Article  PubMed  Google Scholar 

  26. Allen RP, Singer HS, Brown JE, Salam MM. Sleep disorders in Tourette syndrome: a primary or unrelated problem? Pediatr Neurol. 1992;8(4):275–80.

    Article  CAS  PubMed  Google Scholar 

  27. Hibberd C, Charman T, Bhatoa RS, Tekes S, Hedderly T, Gringras P, et al. Sleep difficulties in children with Tourette syndrome and chronic tic disorders: a systematic review of characteristics and associated factors. Sleep. 2020;43(6):zsz308.

    Article  PubMed  Google Scholar 

  28. Quezada J, Coffman KA. Current approaches and new developments in the pharmacological management of Tourette syndrome. CNS Drugs. 2018;32(1):33–45.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Bruni O, Angriman M, Melegari MG, Ferri R. Pharmacotherapeutic management of sleep disorders in children with neurodevelopmental disorders. Expert Opin Pharmacother. 2019;20(18):2257–71.

    Article  CAS  PubMed  Google Scholar 

  30. Keenan L, Sherlock C, Bramham J, Downes M. Overlapping sleep disturbances in persistent tic disorders and attention-deficit hyperactivity disorder: a systematic review and meta-analysis of polysomnographic findings. Neurosci Biobehav Rev. 2021;126:194–212.

    Article  PubMed  Google Scholar 

  31. Romano A, Cundari G, Bruni O, Cardona F. Tic disorders and arousal dysfunction: clinical evaluation of 49 children and adolescents. Minerva Pediatr. 2004;56(3):327–34.

    CAS  PubMed  Google Scholar 

  32. Godar SC, Bortolato M. What makes you tic? Translational approaches to study the role of stress and contextual triggers in Tourette syndrome. Neurosci Biobehav Rev. 2017;76(Pt A):123–33. https://doi.org/10.1016/j.neubiorev.2016.10.003.

    Article  PubMed  Google Scholar 

  33. Kirov R, Becker A, Rothenberger A. Sleep in Tourette syndrome. Curr Dev Disord Rep. 2014;1(4):252–9. https://doi.org/10.1007/s40474-014-0028-0.

    Article  Google Scholar 

  34. Comings DE, Comings BG. A controlled study of Tourette syndrome. I. Attention-deficit disorder, learning disorders, and school problems. Am J Hum Genet. 1987;41(5):701.

    CAS  PubMed  PubMed Central  Google Scholar 

  35. Ricketts EJ, Burgess HJ, Montalbano GE, Coles ME, McGuire JF, Thamrin H, et al. Morning light therapy in adults with Tourette’s disorder. J Neurol. 2022;269(1):399–410. https://doi.org/10.1007/s00415-021-10645-z.

    Article  PubMed  Google Scholar 

  36. Barabas G, Matthews WS, Ferrari M. Somnambulism in children with Tourette syndrome. Dev Med Child Neurol. 1984;26(4):457–60.

    Article  CAS  PubMed  Google Scholar 

  37. Młodzikowska-Albrecht J, Żarowski M, Steinborn B. Sleep disorders in Tourette syndrome in children and adolescents. Neurologia Dziecięca. 2010;11:10–4.

    Google Scholar 

  38. Wand R, Matazow G, Shady G, Furer P, Staley D. Tourette syndrome: associated symptoms and most disabling features. Neurosci Biobehav Rev. 1993;17(3):271–5.

    Article  CAS  PubMed  Google Scholar 

  39. Barabas G, Matthews WS, Ferrari M. Disorders of arousal in Gilles de la Tourette’s syndrome. Neurology. 1984;34(6):815-.

  40. Jankovic J, Rohaidy H. Motor, behavioral and pharmacologic findings in Tourette’s syndrome. Can J Neurol Sci. 1987;14(S3):541–6.

    Article  CAS  PubMed  Google Scholar 

  41. Erenberg G. Sleep disorders in Gilles de la Tourette’s syndrome. 1985.

  42. • Lerner A, Bagic A, Boudreau EA, Hanakawa T, Pagan F, Mari Z, et al. Neuroimaging of neuronal circuits involved in tic generation in patients with Tourette syndrome. Neurology. 2007;68(23):1979–87. https://doi.org/10.1212/01.wnl.0000264417.18604.12. This is the only study to date to perform imaging during sleep in Tourette’s disorder.

  43. •• Nofzinger EA, Buysse DJ, Germain A, Price JC, Miewald JM, Kupfer DJ. Functional neuroimaging evidence for hyperarousal in insomnia. Am J Psychiatry. 2004;161(11):2126–8. This imaging study was the first study to directly support the hyperarousal model of insomnia.

  44. Huang Z, Liang P, Jia X, Zhan S, Li N, Ding Y, et al. Abnormal amygdala connectivity in patients with primary insomnia: evidence from resting state fMRI. Eur J Radiol. 2012;81(6):1288–95.

    Article  PubMed  Google Scholar 

  45. Polyanska L, Critchley HD, Rae CL. Centrality of prefrontal and motor preparation cortices to Tourette syndrome revealed by meta-analysis of task-based neuroimaging studies. NeuroImage: Clinical. 2017;16:257–67.

  46. Müller N, Voderholzer U, Kurtz G, Straube A. Tourette’s syndrome associated with restless legs syndrome and akathisia in a family. Acta Neurol Scand. 1994;89(6):429–32.

    Article  PubMed  Google Scholar 

  47. Rivière J-B, Xiong L, Levchenko A, St-Onge J, Gaspar C, Dion Y, et al. Association of intronic variants of the BTBD9 gene with Tourette syndrome. Arch Neurol. 2009;66(10):1267–72.

    Article  PubMed  Google Scholar 

  48. Earley C, Jones BC, Ferré S. Brain-iron deficiency models of restless legs syndrome. Exp Neurol. 2022;114158.

  49. Cortese S, Lecendreux M, Dalla Bernardina B, Mouren MC, Sbarbati A, Konofal E. Attention-deficit/hyperactivity disorder, Tourette’s syndrome, and restless legs syndrome: the iron hypothesis. Med Hypotheses. 2008;70(6):1128–32.

    Article  CAS  PubMed  Google Scholar 

  50. • Harduf EV, Matzner A, Belelovsky K, Bar-Gad I. Dissociation of tic generation from tic expression during the sleep-wake cycle. Iscience. 2021;24(4):102380. In a mouse model of Tourette’s disorder, study findings showed that during sleep tic expression was blocked by striatal neural activity, suggesting a potential mechanism by which tics may be attenuated during sleep in humans.

  51. Haas H, Panula P. The role of histamine and the tuberomamillary nucleus in the nervous system. Nat Rev Neurosci. 2003;4(2):121–30.

    Article  CAS  PubMed  Google Scholar 

  52. •• Ercan-Sencicek AG, Stillman AA, Ghosh AK, Bilguvar K, O'Roak BJ, Mason CE, et al. L-histidine decarboxylase and Tourette’s syndrome. N Engl J Med. 2010;362(20):1901–8. https://doi.org/10.1056/NEJMoa0907006. This study identified a rare mutation in the L-histidine decarboxylase gene present in all affected family members with Tourette’s disorder across two generations, suggesting involvement of the histaminergic system in Tourette’s disorder.

  53. Baldan LC, Williams KA, Gallezot J-D, Pogorelov V, Rapanelli M, Crowley M, et al. Histidine decarboxylase deficiency causes Tourette syndrome: parallel findings in humans and mice. Neuron. 2014;81(1):77–90.

    Article  PubMed  PubMed Central  Google Scholar 

  54. Hartmann A, Worbe Y, Arnulf I. Increasing histamine neurotransmission in Gilles de la Tourette syndrome. J Neurol. 2012;259(2):375–6.

    Article  PubMed  Google Scholar 

  55. Castaneda TR, de Prado BM, Prieto D, Mora F. Circadian rhythms of dopamine, glutamate and GABA in the striatum and nucleus accumbens of the awake rat: modulation by light. J Pineal Res. 2004;36(3):177–85.

    Article  CAS  PubMed  Google Scholar 

  56. Mendoza J, Challet E. Circadian insights into dopamine mechanisms. Neuroscience. 2014;282:230–42. https://doi.org/10.1016/j.neuroscience.2014.07.081.

    Article  CAS  PubMed  Google Scholar 

  57. Mesgar S, Jameie SB, Aliaghaei A, Parvardeh S, Torabi A, Haghparast A. Dopamine D1 receptor-mediated regulation of Per1, Per2, CLOCK, and BMAL1 expression in the suprachiasmatic nucleus in adult male rats. J Mol Neurosci. 2022;72(3):618–25.

    Article  CAS  PubMed  Google Scholar 

  58. Imbesi M, Yildiz S, Arslan AD, Sharma R, Manev H, Uz T. Dopamine receptor-mediated regulation of neuronal “clock” gene expression. Neuroscience. 2009;158(2):537–44.

    Article  CAS  PubMed  Google Scholar 

  59. Ganos C. Tics and Tourette’s: update on pathophysiology and tic control. Curr Opin Neurol. 2016;29(4):513–8. https://doi.org/10.1097/wco.0000000000000356.

    Article  PubMed  Google Scholar 

  60. Ganos C, Roessner V, Munchau A. The functional anatomy of Gilles de la Tourette syndrome. Neurosci Biobehav Rev. 2013;37(6):1050–62. https://doi.org/10.1016/j.neubiorev.2012.11.004.

    Article  PubMed  Google Scholar 

  61. Braun AR, Stoetter B, Randolph C, Hsiao JK, Vladar K, Gernert J, et al. The functional neuroanatomy of Tourette’s syndrome: an FDG-PET study. I. Regional changes in cerebral glucose metabolism differentiating patients and controls. Neuropsychopharmacology. 1993;9(4):277–91. https://doi.org/10.1038/npp.1993.64.

    Article  CAS  PubMed  Google Scholar 

  62. Eidelberg D, Moeller JR, Antonini A, Kazumata K, Dhawan V, Budman C, et al. The metabolic anatomy of Tourette’s syndrome. Neurology. 1997;48(4):927–34. https://doi.org/10.1212/wnl.48.4.927.

    Article  CAS  PubMed  Google Scholar 

  63. Pourfar M, Feigin A, Tang CC, Carbon-Correll M, Bussa M, Budman C, et al. Abnormal metabolic brain networks in Tourette syndrome. Neurology. 2011;76(11):944–52. https://doi.org/10.1212/WNL.0b013e3182104106.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  64. Ganos C, Kahl U, Brandt V, Schunke O, Bäumer T, Thomalla G, et al. The neural correlates of tic inhibition in Gilles de la Tourette syndrome. Neuropsychologia. 2014;65:297–301.

    Article  PubMed  Google Scholar 

  65. Neuner I, Werner CJ, Arrubla J, Stöcker T, Ehlen C, Wegener HP, et al. Imaging the where and when of tic generation and resting state networks in adult Tourette patients. Front Hum Neurosci. 2014;8:362.

    Article  PubMed  PubMed Central  Google Scholar 

  66. Jackson SR, Loayza J, Crighton M, Sigurdsson HP, Dyke K, Jackson GM. The role of the insula in the generation of motor tics and the experience of the premonitory urge-to-tic in Tourette syndrome. Cortex. 2020;126:119–33.

    Article  PubMed  Google Scholar 

  67. Nofzinger EA, Mintun MA, Price J, Meltzer CC, Townsend D, Buysse DJ, et al. A method for the assessment of the functional neuroanatomy of human sleep using FDG PET. Brain Res Protoc. 1998;2(3):191–8.

    Article  CAS  Google Scholar 

  68. Thomas M, Sing H, Belenky G, Holcomb H, Mayberg H, Dannals R, et al. Neural basis of alertness and cognitive performance impairments during sleepiness. I. Effects of 24 h of sleep deprivation on waking human regional brain activity. J Sleep Res. 2000;9(4):335–52. https://doi.org/10.1046/j.1365-2869.2000.00225.x.

    Article  CAS  PubMed  Google Scholar 

  69. Wu JC, Gillin JC, Buchsbaum MS, Chen P, Keator DB, Khosla WuN, et al. Frontal lobe metabolic decreases with sleep deprivation not totally reversed by recovery sleep. Neuropsychopharmacology. 2006;31(12):2783–92. https://doi.org/10.1038/sj.npp.1301166.

    Article  PubMed  Google Scholar 

  70. Taylor BJ, Hasler BP. Chronotype and mental health: recent advances. Curr Psychiatry Rep. 2018;20(8):59. https://doi.org/10.1007/s11920-018-0925-8.

    Article  PubMed  Google Scholar 

  71. Hastings MH, Maywood ES, Brancaccio M. Generation of circadian rhythms in the suprachiasmatic nucleus. Nat Rev Neurosci. 2018;19(8):453–69.

    Article  CAS  PubMed  Google Scholar 

  72. Buijs RM, Tinoco ECS, Alvarado GH, Escobar C. The circadian system: from clocks to physiology. Handb Clin Neurol. 2021;179:233–47.

    Article  PubMed  Google Scholar 

  73. Miyazaki S, Tahara Y, Colwell CS, Block GD, Nakamura W, Nakamura TJ. Chronic methamphetamine uncovers a circadian rhythm in multiple-unit neural activity in the dorsal striatum which is independent of the suprachiasmatic nucleus. Neurobiol Sleep Circadian Rhythms. 2021;11:100070.

    Article  PubMed  PubMed Central  Google Scholar 

  74. Hampp G, Ripperger JA, Houben T, Schmutz I, Blex C, Perreau-Lenz S, et al. Regulation of monoamine oxidase A by circadian-clock components implies clock influence on mood. Curr Biol. 2008;18(9):678–83.

    Article  CAS  PubMed  Google Scholar 

  75. Ferris MJ, España RA, Locke JL, Konstantopoulos JK, Rose JH, Chen R, et al. Dopamine transporters govern diurnal variation in extracellular dopamine tone. Proc Natl Acad Sci. 2014;111(26):E2751–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  76. Natsubori A, Honma Ki, Honma S. Dual regulation of clock gene Per2 expression in discrete brain areas by the circadian pacemaker and methamphetamine-induced oscillator in rats. Eur J Neurosci. 2014;39(2):229–40.

  77. Fifel K, Meijer JH, Deboer T. Circadian and homeostatic modulation of multi-unit activity in midbrain dopaminergic structures. Sci Rep. 2018;8(1):1–14.

    Article  CAS  Google Scholar 

  78. Pradel K, Drwięga G, Chrobok L, Błasiak T. Racing and pacing in the reward system: a multi-clock circadian control over dopaminergic signalling. Front Physiol. 2022;1288.

  79. Grippo RM, Purohit AM, Zhang Q, Zweifel LS, Güler AD. Direct midbrain dopamine input to the suprachiasmatic nucleus accelerates circadian entrainment. Curr Biol. 2017;27(16):2465-75.e3.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  80. Yujnovsky I, Hirayama J, Doi M, Borrelli E, Sassone-Corsi P. Signaling mediated by the dopamine D2 receptor potentiates circadian regulation by CLOCK: BMAL1. Proceedings of the National Academy of Sciences. 2006;103(16):6386–91.

  81. • Brami-Cherrier K, Lewis RG, Cervantes M, Liu Y, Tognini P, Baldi P, et al. Cocaine-mediated circadian reprogramming in the striatum through dopamine D2R and PPARγ activation. Nature communications. 2020;11(1):1–14. This study showed that dopamine stimulation reprograms the molecular clock found in the striatum. This stuggests the possibility of a similar reprogramming in individuals with Tourette's disorder.

  82. Hood S, Cassidy P, Cossette M-P, Weigl Y, Verwey M, Robinson B, et al. Endogenous dopamine regulates the rhythm of expression of the clock protein PER2 in the rat dorsal striatum via daily activation of D2 dopamine receptors. J Neurosci. 2010;30(42):14046–58.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  83. Badenoch J, Searle T, Watson I, Cavanna AE. Sensory symptoms in body-focused repetitive behaviors, restless legs syndrome, and Tourette syndrome: an overlap? Neurosci Biobehav Rev. 2020;119:320–32. https://doi.org/10.1016/j.neubiorev.2020.10.008.

    Article  PubMed  Google Scholar 

  84. Lipinski JF, Sallee FR, Jackson C, Sethuraman G. Dopamine agonist treatment of Tourette disorder in children: results of an open-label trial of pergolide. Mov Disord. 1997;12(3):402–7. https://doi.org/10.1002/mds.870120320.

    Article  CAS  PubMed  Google Scholar 

  85. Walters AS, LeBrocq C, Passi V, Patel S, Hanna PA, Cohen B, et al. A preliminary look at the percentage of patients with restless legs syndrome who also have Parkinson disease, essential tremor or Tourette syndrome in a single practice. J Sleep Res. 2003;12(4):343–5. https://doi.org/10.1046/j.0962-1105.2003.00368.x.

    Article  PubMed  Google Scholar 

  86. Cortese S, Lecendreux M, Bernardina BD, Mouren MC, Sbarbati A, Konofal E. Attention-deficit/hyperactivity disorder, Tourette’s syndrome, and restless legs syndrome: the iron hypothesis. Med Hypotheses. 2008;70(6):1128–32. https://doi.org/10.1016/j.mehy.2007.10.013.

    Article  CAS  PubMed  Google Scholar 

  87. Avni T, Reich S, Lev N, Gafter-Gvili A. Iron supplementation for restless legs syndrome–a systematic review and meta-analysis. Eur J Intern Med. 2019;63:34–41.

    Article  CAS  PubMed  Google Scholar 

  88. Silber MH, Buchfuhrer MJ, Earley CJ, Koo BB, Manconi M, Winkelman JW, et al. The management of restless legs syndrome: an updated algorithm. Mayo Clin Proc: Elsevier; 2021;1921–37.

  89. Ghosh D, Burkman E. Relationship of serum ferritin level and tic severity in children with Tourette syndrome. Childs Nerv Syst. 2017;33(8):1373–8.

    Article  PubMed  Google Scholar 

  90. Rapanelli M, Pittenger C. Histamine and histamine receptors in Tourette syndrome and other neuropsychiatric conditions. Neuropharmacology. 2016;106:85–90. https://doi.org/10.1016/j.neuropharm.2015.08.019.

    Article  CAS  PubMed  Google Scholar 

  91. Shan L, Dauvilliers Y, Siegel JM. Interactions of the histamine and hypocretin systems in CNS disorders. Nat Rev Neurol. 2015;11(7):401–13. https://doi.org/10.1038/nrneurol.2015.99.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  92. Woods DW, Piacentini J, Chang S, Deckersbach T, Ginsburg G, Peterson A, et al. Managing Tourette syndrome: a behavioral intervention for children and adults therapist guide. Oxford University Press; 2008.

  93. Pringsheim T, Okun MS, Müller-Vahl K, Martino D, Jankovic J, Cavanna AE, et al. Practice guideline recommendations summary: treatment of tics in people with Tourette syndrome and chronic tic disorders. Neurology. 2019;92(19):896–906.

    Article  PubMed  PubMed Central  Google Scholar 

  94. Piacentini J, Woods DW, Scahill L, Wilhelm S, Peterson AL, Chang S, et al. Behavior therapy for children with Tourette disorder: a randomized controlled trial. JAMA. 2010;303(19):1929–37.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  95. Wilhelm S, Peterson AL, Piacentini J, Woods DW, Deckersbach T, Sukhodolsky DG, et al. Randomized trial of behavior therapy for adults with Tourette syndrome. Arch Gen Psychiatry. 2012;69(8):795–803. https://doi.org/10.1001/archgenpsychiatry.2011.1528.

    Article  PubMed  PubMed Central  Google Scholar 

  96. Weisman H, Qureshi IA, Leckman JF, Scahill L, Bloch MH. Systematic review: pharmacological treatment of tic disorders–efficacy of antipsychotic and alpha-2 adrenergic agonist agents. Neurosci Biobehav Rev. 2013;37(6):1162–71.

    Article  CAS  PubMed  Google Scholar 

  97. Tourette Association of America Impact Survey Working Group. 2022 Impact Survey: Assessing the impact of Tourette syndrome and tic disorders on individuals and families. 2022.

  98. Tourette Association of America Impact Survey Working Group. 2018 Impact Survey: assessing the impact of Tourette syndrome and tic disorders on individuals and families. 2018.

  99. Himle MB, Capriotti MR, Hayes LP, Ramanujam K, Scahill L, Sukhodolsky DG, et al. Variables associated with tic exacerbation in children with chronic tic disorders. Behav Modif. 2014;38(2):163–83.

    Article  PubMed  PubMed Central  Google Scholar 

  100. Blake M, Schwartz O, Waloszek JM, Raniti M, Simmons JG, Murray G, et al. The SENSE study: treatment mechanisms of a cognitive behavioral and mindfulness-based group sleep improvement intervention for at-risk adolescents. Sleep. 2017;40(6).

  101. Hiscock H, Sciberras E, Mensah F, Gerner B, Efron D, Khano S, et al. Impact of a behavioural sleep intervention on symptoms and sleep in children with attention deficit hyperactivity disorder, and parental mental health: randomised controlled trial. BMJ. 2015;350.

  102. Murawski B, Wade L, Plotnikoff RC, Lubans DR, Duncan MJ. A systematic review and meta-analysis of cognitive and behavioral interventions to improve sleep health in adults without sleep disorders. Sleep Med Rev. 2018;40:160–9.

    Article  PubMed  Google Scholar 

  103. Reese HE, Vallejo Z, Rasmussen J, Crowe K, Rosenfield E, Wilhelm S. Mindfulness-based stress reduction for Tourette syndrome and chronic tic disorder: a pilot study. J Psychosom Res. 2015;78(3):293–8.

    Article  PubMed  Google Scholar 

  104. Edinger JD, Arnedt JT, Bertisch SM, Carney CE, Harrington JJ, Lichstein KL, et al. Behavioral and psychological treatments for chronic insomnia disorder in adults: an American Academy of Sleep Medicine clinical practice guideline. J Clin Sleep Med. 2021;17(2):255–62.

    Article  PubMed  PubMed Central  Google Scholar 

  105. Cheung JMY, Ji XW, Morin CM. Cognitive behavioral therapies for insomnia and hypnotic medications: considerations and controversies. Sleep Med Clin. 2019;14(2):253–65. https://doi.org/10.1016/j.jsmc.2019.01.006.

    Article  PubMed  Google Scholar 

  106. Ueda K, Black KJ. A comprehensive review of tic disorders in children. J Clin Med. 2021;10(11):2479.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  107. Li J, Somers VK, Xu H, Lopez-Jimenez F, Covassin N. Trends in use of melatonin supplements among US adults, 1999–2018. JAMA. 2022;327(5):483–5.

    Article  PubMed  PubMed Central  Google Scholar 

  108. Panjwani AA, Cowan AE, Jun S, Bailey RL. Trends in nutrient-and non-nutrient–containing dietary supplement use among US children from 1999 to 2016. J Pediatr. 2021;231(131–40):e2.

    Google Scholar 

  109. Smith BL, Ludlow AK. Patterns of nutritional supplement use in children with Tourette syndrome. J Diet Suppl. 2021;1–16. https://doi.org/10.1080/19390211.2021.1958120.

  110. Salanitro M, Wrigley T, Ghabra H, de Haan E, Hill CM, Solmi M, et al. Efficacy on sleep parameters and tolerability of melatonin in individuals with sleep or mental disorders: a systematic review and meta-analysis. Neurosci Biobehav Rev. 2022;139:104723. https://doi.org/10.1016/j.neubiorev.2022.104723.

    Article  PubMed  Google Scholar 

  111. Rzepka-Migut B, Paprocka J. Efficacy and safety of melatonin treatment in children with autism spectrum disorder and attention-deficit/hyperactivity disorder—a review of the literature. Brain Sci. 2020;10(4):219.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  112. Uz T, Arslan AD, Kurtuncu M, Imbesi M, Akhisaroglu M, Dwivedi Y, et al. The regional and cellular expression profile of the melatonin receptor MT1 in the central dopaminergic system. Brain Res Mol Brain Res. 2005;136(1–2):45–53. https://doi.org/10.1016/j.molbrainres.2005.01.002.

    Article  CAS  PubMed  Google Scholar 

  113. • Roth T, Mayleben D, Feldman N, Lankford A, Grant T, Nofzinger E. A novel forehead temperature-regulating device for insomnia: a randomized clinical trial. Sleep. 2018;41(5). https://doi.org/10.1093/sleep/zsy045. This clinical trial showed that frontal cerebral thermal therapy was associated with improvement in sleep onset latency in insomnia, aligning with effects found for prescribed hypnotic medications.

  114. Nofzinger E, Miewald J, Price J, Buysse DJ. Frontal cerebral hypothermia: a new approach to the treatment of insomnia. Sleep. 2009;32:A287–8.

    Google Scholar 

  115. Hallett M. Transcranial magnetic stimulation and the human brain. Nature. 2000;406(6792):147–50. https://doi.org/10.1038/35018000.

    Article  CAS  PubMed  Google Scholar 

  116. Oroz R, Kung S, Croarkin PE, Cheung J. Transcranial magnetic stimulation therapeutic applications on sleep and insomnia: a review. Sleep Sci Pract. 2021;5(1):1–10.

    Google Scholar 

  117. Grados M, Huselid R, Duque-Serrano L. Transcranial magnetic stimulation in Tourette syndrome: a historical perspective, its current use and the influence of comorbidities in treatment response. Brain Sci. 2018;8(7). https://doi.org/10.3390/brainsci8070129.

  118. Sun N, He Y, Wang Z, Zou W, Liu X. The effect of repetitive transcranial magnetic stimulation for insomnia: a systematic review and meta-analysis. Sleep Med. 2021;77:226–37. https://doi.org/10.1016/j.sleep.2020.05.020.

    Article  PubMed  Google Scholar 

  119. Dodson ER, Zee PC. Therapeutics for circadian rhythm sleep disorders. Sleep Med Clin. 2010;5(4):701–15. https://doi.org/10.1016/j.jsmc.2010.08.001.

    Article  PubMed  PubMed Central  Google Scholar 

  120. Burgess HJ, Emens JS. Circadian-based therapies for circadian rhythm sleep-wake disorders. Curr Sleep Med Rep. 2016;2(3):158–65.

    Article  PubMed  PubMed Central  Google Scholar 

  121. Faulkner SM, Bee PE, Meyer N, Dijk D-J, Drake RJ. Light therapies to improve sleep in intrinsic circadian rhythm sleep disorders and neuro-psychiatric illness: a systematic review and meta-analysis. Sleep Med Rev. 2019;46:108–23.

    Article  PubMed  Google Scholar 

  122. Blume C, Garbazza C, Spitschan M. Effects of light on human circadian rhythms, sleep and mood. Somnologie (Berl). 2019;23(3):147–56. https://doi.org/10.1007/s11818-019-00215-x.

    Article  PubMed  Google Scholar 

  123. Brinkhuijsen M, Koenegracht F, Meesters Y. Symptoms of seasonal affective disorder and of obsessive-compulsive disorder reduced by light therapy. J Affect Disord. 2003;74(3):307–8.

    Article  CAS  PubMed  Google Scholar 

  124. Korman M, Palm D, Uzoni A, Faltraco F, Tucha O, Thome J, et al. ADHD 24/7: Circadian clock genes, chronotherapy and sleep/wake cycle insufficiencies in ADHD. World J Biol Psychiatr. 2020;21(3):156–71.

    Article  Google Scholar 

  125. Coles ME, Strauss GP. Shedding light on tics. Psychiatry Res. 2015;225(3):743. https://doi.org/10.1016/j.psychres.2014.12.024.

    Article  PubMed  Google Scholar 

  126. Niederhofter H. Bright light therapy may be a therapeutic option for Tourette’s syndrome. Acta Neuropsychologica. 2009;7(4):283–5.

    Google Scholar 

Download references

Funding

Research reported in this publication was supported in part by funding from the National Institute of Mental Health (NIMH) K23MH113884, Tourette Association of America, and Brain and Behavior Research Foundation grants to Dr. Ricketts. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position these funding agencies.

Author information

Authors and Affiliations

  1. Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, USA

    Emily J. Ricketts, Valerie Swisher & Christopher S. Colwell

  2. Department of Cognitive Science, University of California, San Diego, USA

    Deanna J. Greene

  3. Department of Molecular and Medical Pharmacology, University of California, Los Angeles, USA

    Daniel Silverman

  4. Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, USA

    Eric A. Nofzinger

Authors
  1. Emily J. Ricketts
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Valerie Swisher
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Deanna J. Greene
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Daniel Silverman
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Eric A. Nofzinger
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Christopher S. Colwell
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Emily J. Ricketts.

Ethics declarations

Competing Interests

Dr. Ricketts reports grants from the Tourette Association of America, National Institute of Mental Health, and Brain and Behavior Research Foundation, relevant to the submitted work. She also reports grants and personal fees from the Tourette Association of America, grants from National Heart, Lung, and Blood Institute: Programs to Increase Diversity among Individuals in Health-Related Research; personal fees from Centers for Disease Control and Prevention, personal fees from Springer Nature, and service on the Tourette Association of America Diversity Committee, outside the submitted work. Ms. Swisher, Dr. Greene, and Dr. Silverman have nothing to disclose. Dr. Nofzinger reports being the Founder, Inventor, and Chief Medical Office of Ebb Therapeutics (formerly known as Cerêve, Inc.), a company that manufactured devices to administer frontal cerebral thermal therapy for insomnia, relevant to the submitted work and outside the submitted work. In addition, Dr. Nofzinger has multiple patents related to the frontal cerebral thermal therapy device, with royalties received on University of Pittsburgh license to Ebb Therapeutics. Dr. Colwell reports unpaid consulting for RealSleep™, outside the submitted work.

Human and Animal Rights and Informed Consent

All reported studies/experiments with human or animal subjects performed by the authors have been previously published and complied with all applicable ethical standards (including the Helsinki declaration and its amendments, institutional/national research committee standards, and international/national/institutional guidelines).

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical collection on Sleep and Neurological Conditions

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ricketts, E.J., Swisher, V., Greene, D.J. et al. Sleep Disturbance in Tourette’s Disorder: Potential Underlying Mechanisms. Curr Sleep Medicine Rep 9, 10–22 (2023). https://doi.org/10.1007/s40675-022-00242-5

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40675-022-00242-5

Keywords

Search

Navigation